• head_banner_01

factory Outlets for Piperidinium Acetate - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our well-equipped facilities and excellent quality control throughout all stages of production enables us to guarantee total customer satisfaction for Acetate Acid, Acetate Periodic Table, 10 Mm Ammonium Acetate, We Sincerely welcome customers from all over the world to visit us, with our multifaceted cooperation and work together to develop new markets, create win-win brilliant future.
factory Outlets for Piperidinium Acetate - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

factory Outlets for Piperidinium Acetate - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

factory Outlets for Piperidinium Acetate - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

We always get the job done to be a tangible staff to ensure that we can easily offer you the best high-quality and the greatest value for factory Outlets for Piperidinium Acetate - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Pakistan, Lithuania, Japan, Our company is an international supplier on this kind of merchandise. We supply an amazing selection of high-quality merchandise. Our goal is to delight you with our distinctive collection of mindful items while providing value and excellent service. Our mission is simple: To supply the best items and service to our customers at the lowest prices possible.
  • The company has a good reputation in this industry, and finally it tured out that choose them is a good choice.
    5 Stars By Camille from USA - 2017.01.11 17:15
    Staff is skilled, well-equipped, process is specification, products meet the requirements and delivery is guaranteed, a best partner!
    5 Stars By Andy from Egypt - 2017.10.23 10:29
    Write your message here and send it to us